reSee.it - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
One breast cancer drug costs over $16,000 per bottle in America. The same drug, from the same factory and company, costs one sixth the price in Australia. In Sweden, the identical product costs one tenth the American price.

Video Saved From X

reSee.it Video Transcript AI Summary
A businessman told the speaker that the same fat shot drug cost him $88 in London, but $1,300 in New York. He was stunned that the identical pill, made in the same plant by the same company, had such different prices. The speaker discussed this with drug company representatives. They argued for about half an hour, but ultimately the representative admitted there was no justification for the price difference.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 argues that 100-year-old automotive technology is continually refined and that exhaust from modern cars is cleaner than the air entering the intake in many cities, due to catalytic converters, NOx converters (notably in diesels), computer-controlled fuel injection, and stop-start systems. He claims that there is no justification for restricting petrol cars and contrasts this with restrictions on electric vehicles (EVs). He contends that the EV push is not about encouraging people to switch to EVs for environmental reasons but about driving people out of internal combustion engine (ICE) cars. The EV zero-emission vehicle mandate, he says, forces automotive manufacturers to sell an ever-increasing proportion of EVs each year, and he asserts this will destroy, bankrupt, and reduce mass-manufacturing conglomerates such as Volkswagen, Audi Group, Ford, and others. He cites an example with Volkswagen and Audi: they are not allowed to sell the desired mix of petrol and diesel vehicles because they will be fined £15,000 per car if they fail to sell 28% as EVs. He claims they are already restricting petrol and diesel sales, and notes that this pressure is already in place for 2025. He argues that European carmakers cannot sell many EVs because European cars are more expensive than cheaper Chinese imports. He shifts to a broader geopolitical economic view, stating this is not a mere consumer issue but a plan arranged by global financiers, describing it as a one-two punch: you cannot sell petrol and diesel because of mandates, and your cars are uncompetitive with cheaper Chinese imports. He notes there are 180 Chinese EV makers, with only one or two currently profitable; trade press reports suggest that by the end of the decade, seven to nine of them will be profitable while the rest will have failed. From this, he infers that someone is willing to spend hundreds of billions of dollars to manufacture cars at a loss so they can be delivered to Europe at a loss in order to destroy Europe’s mass-manufacturing capability. He concludes that as a result, there will simply not be enough cars to go around, and ultimately, the mandates will be moot because there will be none available.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker checked the stock app on their iPhone and saw that Tesla stock was down $2.25. The speaker joked that Tesla owners could remove the Tesla logo from their cars with dental floss.

Video Saved From X

reSee.it Video Transcript AI Summary
A regular Ford car costing $175,000 is being purchased in London for $10,000 daily, highlighting a "crazy" system. The FDA will fully support the executive order, which is considered transformative.

Video Saved From X

reSee.it Video Transcript AI Summary
The President has initiated a complete restructuring of the international trading system with a fair and reciprocal plan. For too long other countries have damaged our defense industrial base and threatened our national security. Take Europe, for example. The US runs a $230 billion trade deficit with them, especially in the auto industry. A Cadillac faces tariffs and VAT taxes that significantly increase its price in Germany, while a BMW coming to the US gets rebates, allowing it to be sold much cheaper. This disparity explains why Germany sells us eight times more cars than we sell them. To address this, we're going to identify how countries are unfairly exploiting us through tariffs and non-monetary barriers. Then we will determine reciprocal tariffs to counteract this unfairness, ensuring fair treatment for America. This isn't a political issue, it's an American issue. We want jobs, factories, and a strong defense industrial base here at home so we can be safe, secure, and prosperous.

Video Saved From X

reSee.it Video Transcript AI Summary
The U.S. spends $1,126 per capita on drugs, while Britain spends about $240, roughly one-fifth of the U.S. amount, a trend seen across Europe. Drug companies claim America must pay for innovation. President Trump argues that European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. will no longer subsidize them. If Europeans raise drug prices by 20%, $10 trillion could be spent on innovation, improving global health through better products.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 1 says people repairing their own vehicles is fine in general, but not for warranty work because the cars are “very complicated” and the company does not think it is safe. They argue many repairs cannot be done at home; the speaker says they can work on a 1973 Bronco, but working on a brand new Bronco requires “all sorts of specialty tools,” and not having them could risk people’s lives. Speaker 0 then cites “what real Americans have to say,” stating that if they cannot work on their own vehicle, they expect a “bumper to bumper warranty” for at least 200,000 miles. They connect this to auto manufacturers designing vehicles so they can’t be worked on, claiming that manufacturers do this “that’s how they make their money.” The transcript then discusses data for Ford: about $101 billion in revenue comes from “Ford Blue,” described as parts and service; “Ford Pro” is described as another parts-and-service category with about $66.3 billion in revenue. Speaker 0 concludes that overall Ford makes about $50 billion every year from parts and repairs and says they have “found the real reason why they don’t want you repairing a vehicle.”

Video Saved From X

reSee.it Video Transcript AI Summary
A businessman told the speaker that the same fat shot drug cost him $88 in London but $1,300 in New York. The drugs were identical, made in the same plant by the same company. The speaker discussed this with a representative from the drug companies, who admitted there was no justification for the price difference.

Video Saved From X

reSee.it Video Transcript AI Summary
We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Video Saved From X

reSee.it Video Transcript AI Summary
American patients were subsidizing socialist healthcare systems in the European Union. The European Union is nastier than China, but they will come down a lot. The U.S. has all the cards because the EU treated the U.S. unfairly. The EU sells the U.S. 13 million cars, but the U.S. sells them none. The EU sells the U.S. their agricultural products, but they don't take U.S. products. Because of this unfairness, the EU will have to pay more for healthcare, and the U.S. will have to pay less.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker states that the U.S. will tariff pharmaceuticals. They believe this will cause pharmaceutical companies to move back to the U.S. because the U.S. is the biggest market. The speaker asserts that the U.S.'s advantage is being the biggest market. They say a major tariff on pharmaceuticals will be announced shortly. The speaker believes that upon hearing this, pharmaceutical companies will leave China and other places because most of their product is sold in the U.S.

Video Saved From X

reSee.it Video Transcript AI Summary
One breast cancer drug costs Americans over $16,000 per bottle. The same drug, from the same factory, manufactured by the same company, costs one-sixth the price in Australia. In Sweden, the identical product costs one-tenth the price.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker states that countries represented by the European Union will be told "that game is up." If they "get cute," they won't be able to sell cars into the United States anymore. The speaker claims that European unions and other countries gave drug companies a price, expecting America to pay the difference to cover a shortfall. The speaker says "that's what we did, but we're not doing it anymore."

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker states that countries represented by the European Union will be told "that game is up." If they "get cute," they won't be able to sell cars into the United States anymore. The speaker claims that European Union countries gave drug companies a price, expecting America to pay the difference to cover a shortfall. The speaker says "that's what we did, but we're not doing it anymore."

Video Saved From X

reSee.it Video Transcript AI Summary
A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker highlights the significant price difference, noting one person paid a small amount for the same shot in the UK. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world, according to the speaker, who questions the reason for this disparity.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker claims Major is pressuring Apple to immediately move production to the US. Apple CEO Tim Cook has stated the US lacks a sufficient pool of skilled workers to produce iPhones in the necessary quantities. Outside analysts estimate that even with a US workforce, the cost of an iPhone could triple for American consumers, potentially rising from $1,000 to $3,000 or even $3,500.

Video Saved From X

reSee.it Video Transcript AI Summary
A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

Video Saved From X

reSee.it Video Transcript AI Summary
Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

Video Saved From X

reSee.it Video Transcript AI Summary
Healthcare companies will likely make the same amount of money because it's a redistribution of wealth across the world, not just the European Union. Europe and the rest of the world will pay a little more, while America will pay a lot less. This is due to America having a smaller population compared to the entire world. The top line for healthcare companies could remain the same, but it will be distributed differently.

Video Saved From X

reSee.it Video Transcript AI Summary
The U.S. government, through the State Department, is apparently spending $400 million in taxpayer money on "armored Tesla production units." It raises questions about potential corruption and who benefits from this deal. This contract was not initiated during the Trump administration, but rather approved under Joe Biden.

Video Saved From X

reSee.it Video Transcript AI Summary
Americans are programmed to trust only FDA-approved drugs, but Big Pharma buys the FDA's approval. The FDA stopped independently reviewing all drugs about 30 years ago. Drugmakers can pay a lump sum upfront, such as $10,000,000, to get immediate approval to sell their products. The approval is granted if the drugmaker believes and can prove through their own research studies that the drug is safe and effective.

Video Saved From X

reSee.it Video Transcript AI Summary
I have a Tesla. I got it because it's a cool car. Nothing to do with its green aspirations, which I don't buy into anyways. But in The US, the largest segment of employment in The United States is driver. And the FSD is to the point now, it will be within the next six months, it's gonna eliminate over time all of those jobs. When I asked AI about it, it said in ten years, you will be perceived as a, an insane person for wanting to drive your own car, and you'll be banished. Driving is just like, forget it, unless you live in an inner city and you take mass transit all over. But for most of us in the world here in North America, driving is fundamental to our day to day existence.

PBD Podcast

Ferrari's EV Disaster, Pope's AI Warning + Mamdani's "Transfer Ownership" Plan | PBD #807
Guests: Mamdani
reSee.it Podcast Summary
The conversation covers business and economic news alongside multiple policy and market reactions. They begin with reactions to Ferrari’s newly announced $640,000 all-electric model, discussing whether the move fits the brand’s long-established customer base and noting concerns about depreciation from prior hybrid and electric experiments. They contrast this with Porsche’s recent financial decline and sales weakness tied to its electric strategy. The hosts also discuss European emissions pressure and how regulatory demands can drive manufacturers toward products that do not align with consumer expectations, contributing to both reputational and financial strain. They then shift to political and social developments, including warnings from the Pope about advanced computer systems and debates about how such technologies should be governed, especially in relation to misinformation, weapons risks, and power concentration. Other segments address housing policy rhetoric in New York City, election outcomes and their implications for future races, and a discussion of how constitutional rules and responsibility differ when people own potentially harmful tools. The episode also reviews Middle East diplomacy signals involving Iran, expectations for peace conditions, and why oil prices could change if markets believe negotiations are progressing. Finally, the hosts examine labor market signals and consumer sentiment. They cite a weak summer job outlook for teenagers, linking it to household strain, fuel costs, and broader hiring caution. They compare the possibility that automation-driven software changes may still increase demand for programmers, while emphasizing the need for oversight and clear responsibility. The episode closes with a debate about founder regret after selling a company and with stories about high-risk investing, including an early loan to Elon Musk and lessons about identifying talent, measuring decision patterns, and building the right network.
View Full Interactive Feed